Single Dose of Ivermectin is not Useful in Patients with Hematological Disorders and COVID-19 Illness: A Phase II B Open Labelled Randomized Controlled Trial

{ 'indexed': {'date-parts': [[2022, 5, 27]], 'date-time': '2022-05-27T07:41:20Z', 'timestamp': 1653637280094}, 'reference-count': 23, 'publisher': 'Springer Science and Business Media LLC', 'license': [ { 'start': { 'date-parts': [[2022, 5, 27]], 'date-time': '2022-05-27T00:00:00Z', 'timestamp': 1653609600000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.springer.com/tdm'}, { 'start': { 'date-parts': [[2022, 5, 27]], 'date-time': '2022-05-27T00:00:00Z', 'timestamp': 1653609600000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://www.springer.com/tdm'}], 'funder': [ { 'DOI': '10.13039/501100001843', 'name': 'Science and Engineering Research Board', 'doi-asserted-by': 'publisher', 'award': ['CVD/2020/000990']}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'DOI': '10.1007/s12288-022-01546-w', 'type': 'journal-article', 'created': {'date-parts': [[2022, 5, 27]], 'date-time': '2022-05-27T06:02:46Z', 'timestamp': 1653631366000}, 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Single Dose of Ivermectin is not Useful in Patients with Hematological Disorders and COVID-19 ' 'Illness: A Phase II B Open Labelled Randomized Controlled Trial', 'prefix': '10.1007', 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-9847-9501', 'authenticated-orcid': False, 'given': 'Biju', 'family': 'George', 'sequence': 'first', 'affiliation': []}, {'given': 'Mahesh', 'family': 'Moorthy', 'sequence': 'additional', 'affiliation': []}, {'given': 'Uday', 'family': 'Kulkarni', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sushil', 'family': 'Selvarajan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Priscilla', 'family': 'Rupali', 'sequence': 'additional', 'affiliation': []}, {'given': 'D. J.', 'family': 'Christopher', 'sequence': 'additional', 'affiliation': []}, {'given': 'T.', 'family': 'Balamugesh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Winsley', 'family': 'Rose', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kavitha M.', 'family': 'Lakshmi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anup J.', 'family': 'Devasia', 'sequence': 'additional', 'affiliation': []}, {'given': 'N. A.', 'family': 'Fouzia', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anu', 'family': 'Korula', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sharon', 'family': 'Lionel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Aby', 'family': 'Abraham', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vikram', 'family': 'Mathews', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2022, 5, 27]]}, 'reference': [ { 'issue': '395', 'key': '1546_CR1', 'doi-asserted-by': 'publisher', 'first-page': '1907', 'DOI': '10.1016/S0140-6736(20)31187-9', 'volume': '20', 'author': 'NM Kuderer', 'year': '2020', 'unstructured': 'Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR et al ' '(2020) Clinical impact of COVID-19 on patients with cancer (CCC19): a ' 'cohort study. Lancet 20(395):1907–1918', 'journal-title': 'Lancet'}, { 'issue': '3', 'key': '1546_CR2', 'doi-asserted-by': 'publisher', 'first-page': '335', 'DOI': '10.1016/S1470-2045(20)30096-6', 'volume': '21', 'author': 'W Liang', 'year': '2020', 'unstructured': 'Liang W, Guan W, Chen R, Wang W, Li J, Xu K et al (2020) Cancer patients ' 'in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol ' '21(3):335–337', 'journal-title': 'Lancet Oncol'}, { 'issue': '395', 'key': '1546_CR3', 'first-page': '1907', 'volume': '20', 'author': 'LYW Lee', 'year': '2020', 'unstructured': 'Lee LYW, Cazier J-B, Angelis V, Arnold R, Bisht V, Campton NA et al ' '(2020) COVID-19 mortality in patients with cancer on chemotherapy or ' 'other anticancer treatments: a prospective cohort study. Lancet ' '20(395):1907–1926', 'journal-title': 'Lancet'}, { 'issue': '10', 'key': '1546_CR4', 'doi-asserted-by': 'publisher', 'first-page': 'e737', 'DOI': '10.1016/S2352-3026(20)30251-9', 'volume': '7', 'author': 'F Passamonti', 'year': '2020', 'unstructured': 'Passamonti F, Cattaneo C, Arcaini L et al (2020) Clinical ' 'characteristics and risk factors associated with COVID-19 severity in ' 'patients with hematological malignancies in Italy: a retrospective ' 'multicenter cohort study. Lancet Haematol 7(10):e737–e745', 'journal-title': 'Lancet Haematol'}, { 'key': '1546_CR5', 'doi-asserted-by': 'publisher', 'first-page': '21', 'DOI': '10.1186/s40164-020-00177-z', 'volume': '9', 'author': 'JL Pinana', 'year': '2020', 'unstructured': 'Pinana JL, Martino R, Garcia IG et al (2020) Risk factors and outcomes ' 'of COVID19 in patients with hematological malignancies. Exp Hematol ' 'Oncol 9:21. https://doi.org/10.1186/s40164-020-00177-z', 'journal-title': 'Exp Hematol Oncol'}, { 'issue': '12', 'key': '1546_CR6', 'doi-asserted-by': 'publisher', 'first-page': '1177', 'DOI': '10.1056/NEJMc2001737', 'volume': '382', 'author': 'L Zou', 'year': '2020', 'unstructured': 'Zou L, Ruan F, Huang M et al (2020) SARS-CoV-2 Viral Load in Upper ' 'Respiratory Specimens of infected patients. NEJM 382(12):1177–1179', 'journal-title': 'NEJM'}, { 'issue': '6', 'key': '1546_CR7', 'doi-asserted-by': 'publisher', 'first-page': '656', 'DOI': '10.1016/S1473-3099(20)30232-2', 'volume': '20', 'author': 'Y Liu', 'year': '2020', 'unstructured': 'Liu Y, Yan L-M, Wan L, Xiang T-X, Le A, Liu J-M et al (2020) Viral ' 'dynamics in mild and severe cases of COVID-19. Lancet Infect Dis ' '20(6):656–657', 'journal-title': 'Lancet Infect Dis'}, { 'issue': '9', 'key': '1546_CR8', 'doi-asserted-by': 'publisher', 'first-page': '1150', 'DOI': '10.1164/rccm.202003-0524LE', 'volume': '201', 'author': 'D Chang', 'year': '2020', 'unstructured': 'Chang D, Mo G, Yuan X, Tao Y, Peng X, Wang F et al (2020) Time kinetics ' 'of viral clearance and resolution of symptoms in novel coronavirus ' 'infection. Am J Respir Crit Care Med 201(9):1150–1152', 'journal-title': 'Am J Respir Crit Care Med'}, { 'issue': '10229', 'key': '1546_CR9', 'doi-asserted-by': 'publisher', 'first-page': '1054', 'DOI': '10.1016/S0140-6736(20)30566-3', 'volume': '395', 'author': 'F Zhou', 'year': '2020', 'unstructured': 'Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al (2020) Clinical course and ' 'risk factors for mortality of adult inpatients with COVID-19 in Wuhan, ' 'China: a retrospective cohort study. Lancet 395(10229):1054–1062', 'journal-title': 'Lancet'}, { 'issue': '6', 'key': '1546_CR10', 'doi-asserted-by': 'publisher', 'first-page': '989', 'DOI': '10.3390/v13060989', 'volume': '13', 'author': 'AA Samaha', 'year': '2021', 'unstructured': 'Samaha AA, Mouawia H, Fawaz M et al (2021) Effects of a single dose of ' 'ivermectin on viral and clinical outcomes in asymptomatic SARS—Cov 2 ' 'infected subjects: a pilot clinical trial in Lebanon. Viruses 13(6):989', 'journal-title': 'Viruses'}, { 'key': '1546_CR11', 'doi-asserted-by': 'publisher', 'first-page': 'n949', 'DOI': '10.1136/bmj.n949', 'volume': '373', 'author': 'JJ Bartoszko', 'year': '2021', 'unstructured': 'Bartoszko JJ, Siemieniuk RAC, Kum E et al (2021) Prophylaxis against ' 'COVID-19: living systematic review and network meta-analysis. BMJ ' '373:n949. https://doi.org/10.1136/bmj.n949', 'journal-title': 'BMJ'}, { 'key': '1546_CR12', 'doi-asserted-by': 'publisher', 'first-page': '100720', 'DOI': '10.1016/j.eclinm.2020.100720', 'volume': '32', 'author': 'C Chaccour', 'year': '2021', 'unstructured': 'Chaccour C, Casellas A, Di Matteo AB et al (2021) The effect of early ' 'treatment with ivermectin on viral load, symptoms and humoral response ' 'in patients with non-severe COVID-19: a pilot, double-blind, ' 'placebo-controlled, randomized clinical trial. E Clin Med 32:100720. ' 'https://doi.org/10.1016/j.eclinm.2020.100720', 'journal-title': 'E Clin Med'}, { 'issue': '14', 'key': '1546_CR13', 'doi-asserted-by': 'publisher', 'first-page': '1426', 'DOI': '10.1001/jama.2021.3071', 'volume': '325', 'author': 'E Lopez-Medina', 'year': '2021', 'unstructured': 'Lopez-Medina E, Lopez P, Hurtado IC et al (2021) Effect of ivermectin on ' 'time to resolution of symptoms among adults with mild COVID-19: a ' 'randomized clinical trial. JAMA 325(14):1426–1435', 'journal-title': 'JAMA'}, { 'key': '1546_CR14', 'doi-asserted-by': 'publisher', 'author': 'S Abd-Elsalam', 'year': '2021', 'unstructured': 'Abd-Elsalam S, Noor RA, Badawi R et al (2021) Clinical study evaluating ' 'the efficacy of ivermectin in COVID-19 treatment: a randomized ' 'controlled study. J Med Virol. https://doi.org/10.1002/jmv.27122', 'journal-title': 'J Med Virol', 'DOI': '10.1002/jmv.27122'}, { 'key': '1546_CR15', 'doi-asserted-by': 'publisher', 'author': 'L Shahbaznejad', 'year': '2021', 'unstructured': 'Shahbaznejad L, Davoudi A, Eslami G et al (2021) Effects of ivermectin ' 'in patients with COVID-19: a multicenter, double-blind, randomized, ' 'controlled clinical trial. Clin Ther. ' 'https://doi.org/10.1016/j.clinthera.2021.04.007', 'journal-title': 'Clin Ther', 'DOI': '10.1016/j.clinthera.2021.04.007'}, { 'issue': '5', 'key': '1546_CR16', 'doi-asserted-by': 'publisher', 'first-page': '300060521101355', 'DOI': '10.1177/03000605211013550', 'volume': '49', 'author': 'R Mahmud', 'year': '2021', 'unstructured': 'Mahmud R, Rahman MM, Alam I et al (2021) Ivermectin in combination with ' 'doxycycline for treating COVID-19 symptoms: a randomized trial. J Int ' 'Med Res 49(5):3000605211013550. ' 'https://doi.org/10.1177/03000605211013550', 'journal-title': 'J Int Med Res'}, { 'issue': '3', 'key': '1546_CR17', 'doi-asserted-by': 'publisher', 'first-page': '436', 'DOI': '10.3390/v13030436', 'volume': '13', 'author': 'MM Biernat', 'year': '2021', 'unstructured': 'Biernat MM, Kolasinska A, Kwiatkowski J et al (2021) Early ' 'administration of convalescent plasma improves survival in patients with ' 'hematological malignancies and COVID 19. Viruses 13(3):436', 'journal-title': 'Viruses'}, { 'issue': '20', 'key': '1546_CR18', 'doi-asserted-by': 'publisher', 'first-page': '2290', 'DOI': '10.1182/blood.2020008423', 'volume': '136', 'author': 'T Hueso', 'year': '2020', 'unstructured': 'Hueso T, Pouderoux C, Pere H et al (2020) Convalescent plasma therapy ' 'for B cell depleted patients with protracted COVID-19. Blood ' '136(20):2290–2295', 'journal-title': 'Blood'}, { 'key': '1546_CR19', 'doi-asserted-by': 'publisher', 'first-page': '103075', 'DOI': '10.1016/j.transci.2021.103075', 'volume': '60', 'author': 'P Jeyaraman', 'year': '2021', 'unstructured': 'Jeyaraman P, Agrawal N, Bhargava R et al (2021) Convalescent plasma ' 'therapy for severe COVID 19 in patients with hematological malignancies. ' 'Transfus Apher Sci 60:103075', 'journal-title': 'Transfus Apher Sci'}, { 'issue': '12', 'key': '1546_CR20', 'doi-asserted-by': 'publisher', 'first-page': '2953', 'DOI': '10.1007/s00277-020-04160-w', 'volume': '99', 'author': 'C Villegas', 'year': '2020', 'unstructured': 'Villegas C, Poza M, Talayero P et al (2020) IL-1R blockade is not ' 'effective in patients with hematological malignancies and severe ' 'SARS-Cov-2 infection. Ann Hematol 99(12):2953–2956', 'journal-title': 'Ann Hematol'}, { 'key': '1546_CR21', 'doi-asserted-by': 'publisher', 'first-page': '104787', 'DOI': '10.1016/j.antiviral.2020.104787', 'volume': '178', 'author': 'L Caly', 'year': '2020', 'unstructured': 'Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM (2020) The ' 'FDA-approved drug Ivermectin inhibits the replication of SARS-CoV-2 in ' 'vitro. Antiviral Res 178:104787', 'journal-title': 'Antiviral Res'}, { 'key': '1546_CR22', 'doi-asserted-by': 'publisher', 'first-page': '214', 'DOI': '10.1016/j.ijid.2020.11.191', 'volume': '103', 'author': 'S Ahmed', 'year': '2021', 'unstructured': 'Ahmed S, Karim MM, Ross AG et al (2021) A five-day course of ivermectin ' 'for the treatment of COVID 19 may reduce the duration of illness. Int J ' 'Infect Dis 103:214–216', 'journal-title': 'Int J Infect Dis'}, { 'issue': '1', 'key': '1546_CR23', 'doi-asserted-by': 'publisher', 'first-page': '411', 'DOI': '10.1186/s12879-021-06104-9', 'volume': '21', 'author': 'N Okamus', 'year': '2021', 'unstructured': 'Okamus N, Nemirturk N, Cetinkaya RA et al (2021) Evaluation of the ' 'effectiveness and safety of adding ivermectin to treatment in severe ' 'COVID 19 patients. BMC Infect Dis 21(1):411', 'journal-title': 'BMC Infect Dis'}], 'container-title': 'Indian Journal of Hematology and Blood Transfusion', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://link.springer.com/content/pdf/10.1007/s12288-022-01546-w.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/article/10.1007/s12288-022-01546-w/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/content/pdf/10.1007/s12288-022-01546-w.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2022, 5, 27]], 'date-time': '2022-05-27T07:23:39Z', 'timestamp': 1653636219000}, 'score': 1, 'resource': {'primary': {'URL': 'https://link.springer.com/10.1007/s12288-022-01546-w'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 5, 27]]}, 'references-count': 23, 'alternative-id': ['1546'], 'URL': 'http://dx.doi.org/10.1007/s12288-022-01546-w', 'relation': {}, 'ISSN': ['0971-4502', '0974-0449'], 'subject': ['Hematology'], 'container-title-short': 'Indian J Hematol Blood Transfus', 'published': {'date-parts': [[2022, 5, 27]]}, 'assertion': [ { 'value': '8 February 2022', 'order': 1, 'name': 'received', 'label': 'Received', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '26 April 2022', 'order': 2, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '27 May 2022', 'order': 3, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, {'order': 1, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Declarations'}}, { 'value': 'No conflicts of interest to declare for any of the authors.', 'order': 2, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Conflict of interest'}}, { 'value': 'This content has been made available to all.', 'name': 'free', 'label': 'Free to read'}]}